The Value of Cardiopulmonary Exercise Testing in the Diagnosis and Treatment of Coronary Heart Disease

Abstract

Coronary heart disease is a cardiac condition caused by myocardial ischemia, hypoxia, and even necrosis due to coronary artery atherosclerosis. With the aging population and the increasing prevalence of risk factors such as hypertension, diabetes, and obesity, the incidence of coronary heart disease continues to rise. Despite significant advancements in drug therapy, interventional treatments, and rehabilitation, the morbidity rate of coronary heart disease remains high, posing significant challenges for its diagnosis and prevention. Cardiopulmonary exercise testing, as a non-invasive, objective, quantitative, and comprehensive "gold standard" for evaluating cardiopulmonary function, plays an increasingly important role in the diagnosis, severity assessment, prognosis prediction, and treatment and cardiac rehabilitation evaluation of coronary heart disease. Therefore, research on cardiopulmonary exercise testing in the diagnosis and treatment of coronary heart disease demonstrates good clinical feasibility and application value. The following will briefly describe its application in coronary heart disease.